Human Coagulation Factor IX Market
1 Study Coverage
1.1 Human Coagulation Factor IX Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor IX Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AHGB
1.2.3 AHFB
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Coagulation Factor IX Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Personal Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor IX Sales Estimates and Forecasts 2017-2028
2.2 Global Human Coagulation Factor IX Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Coagulation Factor IX Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Coagulation Factor IX Sales by Region
2.4.1 Global Human Coagulation Factor IX Sales by Region (2017-2022)
2.4.2 Global Sales Human Coagulation Factor IX by Region (2023-2028)
2.5 Global Human Coagulation Factor IX Revenue by Region
2.5.1 Global Human Coagulation Factor IX Revenue by Region (2017-2022)
2.5.2 Global Human Coagulation Factor IX Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Coagulation Factor IX Sales by Manufacturers
3.1.1 Global Top Human Coagulation Factor IX Manufacturers by Sales (2017-2022)
3.1.2 Global Human Coagulation Factor IX Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Coagulation Factor IX in 2021
3.2 Global Human Coagulation Factor IX Revenue by Manufacturers
3.2.1 Global Human Coagulation Factor IX Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Coagulation Factor IX Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor IX Revenue in 2021
3.3 Global Human Coagulation Factor IX Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Coagulation Factor IX Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Coagulation Factor IX Sales by Type
4.1.1 Global Human Coagulation Factor IX Historical Sales by Type (2017-2022)
4.1.2 Global Human Coagulation Factor IX Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Coagulation Factor IX Sales Market Share by Type (2017-2028)
4.2 Global Human Coagulation Factor IX Revenue by Type
4.2.1 Global Human Coagulation Factor IX Historical Revenue by Type (2017-2022)
4.2.2 Global Human Coagulation Factor IX Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Coagulation Factor IX Revenue Market Share by Type (2017-2028)
4.3 Global Human Coagulation Factor IX Price by Type
4.3.1 Global Human Coagulation Factor IX Price by Type (2017-2022)
4.3.2 Global Human Coagulation Factor IX Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Coagulation Factor IX Sales by Application
5.1.1 Global Human Coagulation Factor IX Historical Sales by Application (2017-2022)
5.1.2 Global Human Coagulation Factor IX Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Coagulation Factor IX Sales Market Share by Application (2017-2028)
5.2 Global Human Coagulation Factor IX Revenue by Application
5.2.1 Global Human Coagulation Factor IX Historical Revenue by Application (2017-2022)
5.2.2 Global Human Coagulation Factor IX Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Coagulation Factor IX Revenue Market Share by Application (2017-2028)
5.3 Global Human Coagulation Factor IX Price by Application
5.3.1 Global Human Coagulation Factor IX Price by Application (2017-2022)
5.3.2 Global Human Coagulation Factor IX Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Coagulation Factor IX Market Size by Type
6.1.1 North America Human Coagulation Factor IX Sales by Type (2017-2028)
6.1.2 North America Human Coagulation Factor IX Revenue by Type (2017-2028)
6.2 North America Human Coagulation Factor IX Market Size by Application
6.2.1 North America Human Coagulation Factor IX Sales by Application (2017-2028)
6.2.2 North America Human Coagulation Factor IX Revenue by Application (2017-2028)
6.3 North America Human Coagulation Factor IX Market Size by Country
6.3.1 North America Human Coagulation Factor IX Sales by Country (2017-2028)
6.3.2 North America Human Coagulation Factor IX Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Coagulation Factor IX Market Size by Type
7.1.1 Europe Human Coagulation Factor IX Sales by Type (2017-2028)
7.1.2 Europe Human Coagulation Factor IX Revenue by Type (2017-2028)
7.2 Europe Human Coagulation Factor IX Market Size by Application
7.2.1 Europe Human Coagulation Factor IX Sales by Application (2017-2028)
7.2.2 Europe Human Coagulation Factor IX Revenue by Application (2017-2028)
7.3 Europe Human Coagulation Factor IX Market Size by Country
7.3.1 Europe Human Coagulation Factor IX Sales by Country (2017-2028)
7.3.2 Europe Human Coagulation Factor IX Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Coagulation Factor IX Market Size by Type
8.1.1 Asia Pacific Human Coagulation Factor IX Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Coagulation Factor IX Revenue by Type (2017-2028)
8.2 Asia Pacific Human Coagulation Factor IX Market Size by Application
8.2.1 Asia Pacific Human Coagulation Factor IX Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Coagulation Factor IX Revenue by Application (2017-2028)
8.3 Asia Pacific Human Coagulation Factor IX Market Size by Region
8.3.1 Asia Pacific Human Coagulation Factor IX Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Coagulation Factor IX Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Coagulation Factor IX Market Size by Type
9.1.1 Latin America Human Coagulation Factor IX Sales by Type (2017-2028)
9.1.2 Latin America Human Coagulation Factor IX Revenue by Type (2017-2028)
9.2 Latin America Human Coagulation Factor IX Market Size by Application
9.2.1 Latin America Human Coagulation Factor IX Sales by Application (2017-2028)
9.2.2 Latin America Human Coagulation Factor IX Revenue by Application (2017-2028)
9.3 Latin America Human Coagulation Factor IX Market Size by Country
9.3.1 Latin America Human Coagulation Factor IX Sales by Country (2017-2028)
9.3.2 Latin America Human Coagulation Factor IX Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Coagulation Factor IX Market Size by Type
10.1.1 Middle East and Africa Human Coagulation Factor IX Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Coagulation Factor IX Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Coagulation Factor IX Market Size by Application
10.2.1 Middle East and Africa Human Coagulation Factor IX Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Coagulation Factor IX Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Coagulation Factor IX Market Size by Country
10.3.1 Middle East and Africa Human Coagulation Factor IX Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Coagulation Factor IX Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Overview
11.1.3 Grifols Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Grifols Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Grifols Recent Developments
11.2 Biogen
11.2.1 Biogen Corporation Information
11.2.2 Biogen Overview
11.2.3 Biogen Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biogen Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biogen Recent Developments
11.3 Octapharma
11.3.1 Octapharma Corporation Information
11.3.2 Octapharma Overview
11.3.3 Octapharma Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Octapharma Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Octapharma Recent Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Overview
11.4.3 Baxter Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Baxter Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Recent Developments
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Overview
11.5.3 Bayer Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer Recent Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Overview
11.6.3 CSL Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CSL Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSL Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Corporation Information
11.7.2 Novo Nordisk Overview
11.7.3 Novo Nordisk Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novo Nordisk Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novo Nordisk Recent Developments
11.8 Greencross
11.8.1 Greencross Corporation Information
11.8.2 Greencross Overview
11.8.3 Greencross Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Greencross Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Greencross Recent Developments
11.9 Kedrion
11.9.1 Kedrion Corporation Information
11.9.2 Kedrion Overview
11.9.3 Kedrion Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Kedrion Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Kedrion Recent Developments
11.10 BPL
11.10.1 BPL Corporation Information
11.10.2 BPL Overview
11.10.3 BPL Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BPL Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BPL Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Corporation Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hualan Bio Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Bio Recent Developments
11.12 RAAS
11.12.1 RAAS Corporation Information
11.12.2 RAAS Overview
11.12.3 RAAS Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 RAAS Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 RAAS Recent Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Overview
11.13.3 Pfizer Human Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Coagulation Factor IX Industry Chain Analysis
12.2 Human Coagulation Factor IX Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Coagulation Factor IX Production Mode & Process
12.4 Human Coagulation Factor IX Sales and Marketing
12.4.1 Human Coagulation Factor IX Sales Channels
12.4.2 Human Coagulation Factor IX Distributors
12.5 Human Coagulation Factor IX Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Coagulation Factor IX Industry Trends
13.2 Human Coagulation Factor IX Market Drivers
13.3 Human Coagulation Factor IX Market Challenges
13.4 Human Coagulation Factor IX Market Restraints
14 Key Findings in The Global Human Coagulation Factor IX Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor IX Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of AHGB
Table 3. Major Manufacturers of AHFB
Table 4. Major Manufacturers of Others
Table 5. Global Human Coagulation Factor IX Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Coagulation Factor IX Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Human Coagulation Factor IX Sales by Region (2017-2022) & (K Pcs)
Table 8. Global Human Coagulation Factor IX Sales Market Share by Region (2017-2022)
Table 9. Global Human Coagulation Factor IX Sales by Region (2023-2028) & (K Pcs)
Table 10. Global Human Coagulation Factor IX Sales Market Share by Region (2023-2028)
Table 11. Global Human Coagulation Factor IX Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Human Coagulation Factor IX Revenue Market Share by Region (2017-2022)
Table 13. Global Human Coagulation Factor IX Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Human Coagulation Factor IX Revenue Market Share by Region (2023-2028)
Table 15. Global Human Coagulation Factor IX Sales by Manufacturers (2017-2022) & (K Pcs)
Table 16. Global Human Coagulation Factor IX Sales Share by Manufacturers (2017-2022)
Table 17. Global Human Coagulation Factor IX Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Human Coagulation Factor IX Revenue Share by Manufacturers (2017-2022)
Table 19. Human Coagulation Factor IX Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 20. Global Human Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Human Coagulation Factor IX by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor IX as of 2021)
Table 22. Human Coagulation Factor IX Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Human Coagulation Factor IX Product Offered
Table 24. Date of Manufacturers Enter into Human Coagulation Factor IX Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Coagulation Factor IX Sales by Type (2017-2022) & (K Pcs)
Table 27. Global Human Coagulation Factor IX Sales by Type (2023-2028) & (K Pcs)
Table 28. Global Human Coagulation Factor IX Sales Share by Type (2017-2022)
Table 29. Global Human Coagulation Factor IX Sales Share by Type (2023-2028)
Table 30. Global Human Coagulation Factor IX Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Human Coagulation Factor IX Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Human Coagulation Factor IX Revenue Share by Type (2017-2022)
Table 33. Global Human Coagulation Factor IX Revenue Share by Type (2023-2028)
Table 34. Human Coagulation Factor IX Price by Type (2017-2022) & (USD/Pcs)
Table 35. Global Human Coagulation Factor IX Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 36. Global Human Coagulation Factor IX Sales by Application (2017-2022) & (K Pcs)
Table 37. Global Human Coagulation Factor IX Sales by Application (2023-2028) & (K Pcs)
Table 38. Global Human Coagulation Factor IX Sales Share by Application (2017-2022)
Table 39. Global Human Coagulation Factor IX Sales Share by Application (2023-2028)
Table 40. Global Human Coagulation Factor IX Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Human Coagulation Factor IX Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Human Coagulation Factor IX Revenue Share by Application (2017-2022)
Table 43. Global Human Coagulation Factor IX Revenue Share by Application (2023-2028)
Table 44. Human Coagulation Factor IX Price by Application (2017-2022) & (USD/Pcs)
Table 45. Global Human Coagulation Factor IX Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 46. North America Human Coagulation Factor IX Sales by Type (2017-2022) & (K Pcs)
Table 47. North America Human Coagulation Factor IX Sales by Type (2023-2028) & (K Pcs)
Table 48. North America Human Coagulation Factor IX Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Human Coagulation Factor IX Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Human Coagulation Factor IX Sales by Application (2017-2022) & (K Pcs)
Table 51. North America Human Coagulation Factor IX Sales by Application (2023-2028) & (K Pcs)
Table 52. North America Human Coagulation Factor IX Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Human Coagulation Factor IX Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Human Coagulation Factor IX Sales by Country (2017-2022) & (K Pcs)
Table 55. North America Human Coagulation Factor IX Sales by Country (2023-2028) & (K Pcs)
Table 56. North America Human Coagulation Factor IX Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Human Coagulation Factor IX Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Human Coagulation Factor IX Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Human Coagulation Factor IX Sales by Type (2023-2028) & (K Pcs)
Table 60. Europe Human Coagulation Factor IX Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Human Coagulation Factor IX Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Human Coagulation Factor IX Sales by Application (2017-2022) & (K Pcs)
Table 63. Europe Human Coagulation Factor IX Sales by Application (2023-2028) & (K Pcs)
Table 64. Europe Human Coagulation Factor IX Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Human Coagulation Factor IX Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Human Coagulation Factor IX Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe Human Coagulation Factor IX Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe Human Coagulation Factor IX Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Human Coagulation Factor IX Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Human Coagulation Factor IX Sales by Type (2017-2022) & (K Pcs)
Table 71. Asia Pacific Human Coagulation Factor IX Sales by Type (2023-2028) & (K Pcs)
Table 72. Asia Pacific Human Coagulation Factor IX Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Human Coagulation Factor IX Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Human Coagulation Factor IX Sales by Application (2017-2022) & (K Pcs)
Table 75. Asia Pacific Human Coagulation Factor IX Sales by Application (2023-2028) & (K Pcs)
Table 76. Asia Pacific Human Coagulation Factor IX Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Human Coagulation Factor IX Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Human Coagulation Factor IX Sales by Region (2017-2022) & (K Pcs)
Table 79. Asia Pacific Human Coagulation Factor IX Sales by Region (2023-2028) & (K Pcs)
Table 80. Asia Pacific Human Coagulation Factor IX Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Human Coagulation Factor IX Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Human Coagulation Factor IX Sales by Type (2017-2022) & (K Pcs)
Table 83. Latin America Human Coagulation Factor IX Sales by Type (2023-2028) & (K Pcs)
Table 84. Latin America Human Coagulation Factor IX Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Human Coagulation Factor IX Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Human Coagulation Factor IX Sales by Application (2017-2022) & (K Pcs)
Table 87. Latin America Human Coagulation Factor IX Sales by Application (2023-2028) & (K Pcs)
Table 88. Latin America Human Coagulation Factor IX Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Human Coagulation Factor IX Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Human Coagulation Factor IX Sales by Country (2017-2022) & (K Pcs)
Table 91. Latin America Human Coagulation Factor IX Sales by Country (2023-2028) & (K Pcs)
Table 92. Latin America Human Coagulation Factor IX Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Human Coagulation Factor IX Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Human Coagulation Factor IX Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East and Africa Human Coagulation Factor IX Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East and Africa Human Coagulation Factor IX Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Human Coagulation Factor IX Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Human Coagulation Factor IX Sales by Application (2017-2022) & (K Pcs)
Table 99. Middle East and Africa Human Coagulation Factor IX Sales by Application (2023-2028) & (K Pcs)
Table 100. Middle East and Africa Human Coagulation Factor IX Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Human Coagulation Factor IX Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Human Coagulation Factor IX Sales by Country (2017-2022) & (K Pcs)
Table 103. Middle East and Africa Human Coagulation Factor IX Sales by Country (2023-2028) & (K Pcs)
Table 104. Middle East and Africa Human Coagulation Factor IX Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Human Coagulation Factor IX Revenue by Country (2023-2028) & (US$ Million)
Table 106. Grifols Corporation Information
Table 107. Grifols Description and Major Businesses
Table 108. Grifols Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 109. Grifols Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Grifols Recent Developments
Table 111. Biogen Corporation Information
Table 112. Biogen Description and Major Businesses
Table 113. Biogen Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 114. Biogen Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Biogen Recent Developments
Table 116. Octapharma Corporation Information
Table 117. Octapharma Description and Major Businesses
Table 118. Octapharma Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 119. Octapharma Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Octapharma Recent Developments
Table 121. Baxter Corporation Information
Table 122. Baxter Description and Major Businesses
Table 123. Baxter Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 124. Baxter Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Baxter Recent Developments
Table 126. Bayer Corporation Information
Table 127. Bayer Description and Major Businesses
Table 128. Bayer Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 129. Bayer Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Bayer Recent Developments
Table 131. CSL Corporation Information
Table 132. CSL Description and Major Businesses
Table 133. CSL Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 134. CSL Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. CSL Recent Developments
Table 136. Novo Nordisk Corporation Information
Table 137. Novo Nordisk Description and Major Businesses
Table 138. Novo Nordisk Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Novo Nordisk Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Novo Nordisk Recent Developments
Table 141. Greencross Corporation Information
Table 142. Greencross Description and Major Businesses
Table 143. Greencross Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 144. Greencross Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Greencross Recent Developments
Table 146. Kedrion Corporation Information
Table 147. Kedrion Description and Major Businesses
Table 148. Kedrion Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 149. Kedrion Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Kedrion Recent Developments
Table 151. BPL Corporation Information
Table 152. BPL Description and Major Businesses
Table 153. BPL Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 154. BPL Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. BPL Recent Developments
Table 156. Hualan Bio Corporation Information
Table 157. Hualan Bio Description and Major Businesses
Table 158. Hualan Bio Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 159. Hualan Bio Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Hualan Bio Recent Developments
Table 161. RAAS Corporation Information
Table 162. RAAS Description and Major Businesses
Table 163. RAAS Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 164. RAAS Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. RAAS Recent Developments
Table 166. Pfizer Corporation Information
Table 167. Pfizer Description and Major Businesses
Table 168. Pfizer Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 169. Pfizer Human Coagulation Factor IX Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Pfizer Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Human Coagulation Factor IX Distributors List
Table 174. Human Coagulation Factor IX Customers List
Table 175. Human Coagulation Factor IX Market Trends
Table 176. Human Coagulation Factor IX Market Drivers
Table 177. Human Coagulation Factor IX Market Challenges
Table 178. Human Coagulation Factor IX Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor IX Product Picture
Figure 3. Global Human Coagulation Factor IX Market Share by Type in 2021 & 2028
Figure 3. AHGB Product Picture
Figure 4. AHFB Product Picture
Figure 5. Others Product Picture
Figure 6. Global Human Coagulation Factor IX Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Personal Clinic
Figure 9. Others
Figure 10. Human Coagulation Factor IX Report Years Considered
Figure 11. Global Human Coagulation Factor IX Sales 2017-2028 (K Pcs)
Figure 12. Global Human Coagulation Factor IX Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Coagulation Factor IX Revenue 2017-2028 (US$ Million)
Figure 14. Global Human Coagulation Factor IX Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Human Coagulation Factor IX Sales Market Share by Region (2017-2022)
Figure 16. Global Human Coagulation Factor IX Sales Market Share by Region (2023-2028)
Figure 17. North America Human Coagulation Factor IX Sales YoY (2017-2028) & (K Pcs)
Figure 18. North America Human Coagulation Factor IX Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Human Coagulation Factor IX Sales YoY (2017-2028) & (K Pcs)
Figure 20. Europe Human Coagulation Factor IX Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Human Coagulation Factor IX Sales YoY (2017-2028) & (K Pcs)
Figure 22. Asia-Pacific Human Coagulation Factor IX Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Human Coagulation Factor IX Sales YoY (2017-2028) & (K Pcs)
Figure 24. Latin America Human Coagulation Factor IX Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Human Coagulation Factor IX Sales YoY (2017-2028) & (K Pcs)
Figure 26. Middle East & Africa Human Coagulation Factor IX Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Human Coagulation Factor IX Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Coagulation Factor IX in the World: Market Share by Human Coagulation Factor IX Revenue in 2021
Figure 29. Global Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Human Coagulation Factor IX Sales Market Share by Type (2017-2028)
Figure 31. Global Human Coagulation Factor IX Revenue Market Share by Type (2017-2028)
Figure 32. Global Human Coagulation Factor IX Sales Market Share by Application (2017-2028)
Figure 33. Global Human Coagulation Factor IX Revenue Market Share by Application (2017-2028)
Figure 34. North America Human Coagulation Factor IX Sales Market Share by Type (2017-2028)
Figure 35. North America Human Coagulation Factor IX Revenue Market Share by Type (2017-2028)
Figure 36. North America Human Coagulation Factor IX Sales Market Share by Application (2017-2028)
Figure 37. North America Human Coagulation Factor IX Revenue Market Share by Application (2017-2028)
Figure 38. North America Human Coagulation Factor IX Sales Share by Country (2017-2028)
Figure 39. North America Human Coagulation Factor IX Revenue Share by Country (2017-2028)
Figure 40. U.S. Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Human Coagulation Factor IX Sales Market Share by Type (2017-2028)
Figure 43. Europe Human Coagulation Factor IX Revenue Market Share by Type (2017-2028)
Figure 44. Europe Human Coagulation Factor IX Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Coagulation Factor IX Revenue Market Share by Application (2017-2028)
Figure 46. Europe Human Coagulation Factor IX Sales Share by Country (2017-2028)
Figure 47. Europe Human Coagulation Factor IX Revenue Share by Country (2017-2028)
Figure 48. Germany Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 49. France Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Human Coagulation Factor IX Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Human Coagulation Factor IX Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Human Coagulation Factor IX Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Human Coagulation Factor IX Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Coagulation Factor IX Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Human Coagulation Factor IX Revenue Share by Region (2017-2028)
Figure 59. China Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 62. India Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Human Coagulation Factor IX Sales Market Share by Type (2017-2028)
Figure 70. Latin America Human Coagulation Factor IX Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Human Coagulation Factor IX Sales Market Share by Application (2017-2028)
Figure 72. Latin America Human Coagulation Factor IX Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Human Coagulation Factor IX Sales Share by Country (2017-2028)
Figure 74. Latin America Human Coagulation Factor IX Revenue Share by Country (2017-2028)
Figure 75. Mexico Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Human Coagulation Factor IX Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Human Coagulation Factor IX Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Human Coagulation Factor IX Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Human Coagulation Factor IX Revenue Share by Country (2017-2028)
Figure 84. Turkey Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Human Coagulation Factor IX Revenue (2017-2028) & (US$ Million)
Figure 87. Human Coagulation Factor IX Value Chain
Figure 88. Human Coagulation Factor IX Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
